Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 3
1977 2
1978 3
1979 1
1980 1
1982 3
1983 3
1984 4
1985 4
1986 6
1987 1
1988 4
1989 6
1990 5
1991 6
1992 5
1993 6
1994 4
1995 3
1996 5
1997 3
1998 6
1999 12
2000 6
2001 6
2002 9
2003 9
2004 8
2005 10
2006 11
2007 12
2008 11
2009 17
2010 17
2011 9
2012 23
2013 16
2014 24
2015 16
2016 21
2017 19
2018 22
2019 29
2020 22
2021 21
2022 26
2023 20
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

448 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Glycerol metabolism disease"
Page 1
Aquaporin-3 in the epidermis: more than skin deep.
Bollag WB, Aitkens L, White J, Hyndman KA. Bollag WB, et al. Am J Physiol Cell Physiol. 2020 Jun 1;318(6):C1144-C1153. doi: 10.1152/ajpcell.00075.2020. Epub 2020 Apr 8. Am J Physiol Cell Physiol. 2020. PMID: 32267715 Free PMC article. Review.
Dysregulation of this differentiation program can result in skin diseases, including psoriasis and nonmelanoma skin cancers, among others. Accumulating evidence in the literature indicates that the water-, glycerol-, and hydrogen peroxide-transporting channel aquapo …
Dysregulation of this differentiation program can result in skin diseases, including psoriasis and nonmelanoma skin cancers, among ot …
Early prediction of phenotypic severity in Citrullinemia Type 1.
Zielonka M, Kölker S, Gleich F, Stützenberger N, Nagamani SCS, Gropman AL, Hoffmann GF, Garbade SF, Posset R; Urea Cycle Disorders Consortium (UCDC) and the European Registry and Network for Intoxication type Metabolic Diseases (E-IMD) Consortia Study Group. Zielonka M, et al. Ann Clin Transl Neurol. 2019 Sep;6(9):1858-1871. doi: 10.1002/acn3.50886. Epub 2019 Aug 30. Ann Clin Transl Neurol. 2019. PMID: 31469252 Free PMC article.
OBJECTIVE: Citrullinemia type 1 (CTLN1) is an inherited metabolic disease affecting the brain which is detectable by newborn screening. The clinical spectrum is highly variable including individuals with lethal hyperammonemic encephalopathy in the newborn period and …
OBJECTIVE: Citrullinemia type 1 (CTLN1) is an inherited metabolic disease affecting the brain which is detectable by newborn s …
Serum integrative omics reveals the landscape of human diabetic kidney disease.
Liu S, Gui Y, Wang MS, Zhang L, Xu T, Pan Y, Zhang K, Yu Y, Xiao L, Qiao Y, Bonin C, Hargis G, Huan T, Yu Y, Tao J, Zhang R, Kreutzer DL, Zhou Y, Tian XJ, Wang Y, Fu H, An X, Liu S, Zhou D. Liu S, et al. Mol Metab. 2021 Dec;54:101367. doi: 10.1016/j.molmet.2021.101367. Epub 2021 Nov 1. Mol Metab. 2021. PMID: 34737094 Free PMC article. Clinical Trial.
OBJECTIVE: Diabetic kidney disease (DKD) is the most common microvascular complication of type 2 diabetes mellitus (2-DM). ...First, the training proteomics revealed that the combination of alpha(2)-macroglobulin, cathepsin D, and CD324 could serve as a surrogate protein b …
OBJECTIVE: Diabetic kidney disease (DKD) is the most common microvascular complication of type 2 diabetes mellitus (2-DM). ...First, …
Glycolysis/gluconeogenesis- and tricarboxylic acid cycle-related metabolites, Mediterranean diet, and type 2 diabetes.
Guasch-Ferré M, Santos JL, Martínez-González MA, Clish CB, Razquin C, Wang D, Liang L, Li J, Dennis C, Corella D, Muñoz-Bravo C, Romaguera D, Estruch R, Santos-Lozano JM, Castañer O, Alonso-Gómez A, Serra-Majem L, Ros E, Canudas S, Asensio EM, Fitó M, Pierce K, Martínez JA, Salas-Salvadó J, Toledo E, Hu FB, Ruiz-Canela M. Guasch-Ferré M, et al. Am J Clin Nutr. 2020 Apr 1;111(4):835-844. doi: 10.1093/ajcn/nqaa016. Am J Clin Nutr. 2020. PMID: 32060497 Free PMC article. Clinical Trial.
The weighted score including all metabolites was associated with a 30% (95% CI: 1.12, 1.51) higher relative risk of T2D for each 1-SD increment. ...Lower risks were observed in the MedDiet groups than in the control group although no significant interactions were fo …
The weighted score including all metabolites was associated with a 30% (95% CI: 1.12, 1.51) higher relative risk of T2D for each 1-SD …
Different types of emollient cream exhibit diverse physiological effects on the skin barrier in adults with atopic dermatitis.
Danby SG, Andrew PV, Taylor RN, Kay LJ, Chittock J, Pinnock A, Ulhaq I, Fasth A, Carlander K, Holm T, Cork MJ. Danby SG, et al. Clin Exp Dermatol. 2022 Jun;47(6):1154-1164. doi: 10.1111/ced.15141. Epub 2022 Apr 12. Clin Exp Dermatol. 2022. PMID: 35167133 Free PMC article. Clinical Trial.
AIM: To compare the barrier-strengthening properties of a new moisturizer containing urea and glycerol (urea-glycerol cream; UGC), with those of a glycerol-containing moisturizer (glycerol cream; GC), a simple paraffin cream (PC) with no humectant, and …
AIM: To compare the barrier-strengthening properties of a new moisturizer containing urea and glycerol (urea-glycerol cream; U …
Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease.
Luukkonen PK, Qadri S, Ahlholm N, Porthan K, Männistö V, Sammalkorpi H, Penttilä AK, Hakkarainen A, Lehtimäki TE, Gaggini M, Gastaldelli A, Ala-Korpela M, Orho-Melander M, Arola J, Juuti A, Pihlajamäki J, Hodson L, Yki-Järvinen H. Luukkonen PK, et al. J Hepatol. 2022 Mar;76(3):526-535. doi: 10.1016/j.jhep.2021.10.013. Epub 2021 Oct 25. J Hepatol. 2022. PMID: 34710482 Free PMC article.
CONCLUSIONS: These data show that the mechanisms underlying 'Metabolic' and 'Genetic' components of NAFLD are fundamentally different. These findings may have implications with respect to the diagnosis and treatment of NAFLD. LAY SUMMARY: The pathogenesis of non-alcoholic …
CONCLUSIONS: These data show that the mechanisms underlying 'Metabolic' and 'Genetic' components of NAFLD are fundamentally different …
Predicting the disease severity in male individuals with ornithine transcarbamylase deficiency.
Scharre S, Posset R, Garbade SF, Gleich F, Seidl MJ, Druck AC, Okun JG, Gropman AL, Nagamani SCS, Hoffmann GF, Kölker S, Zielonka M; Urea Cycle Disorders Consortium (UCDC) and the European registry and network for Intoxication type Metabolic Diseases (E-IMD) Consortia Study Group. Scharre S, et al. Ann Clin Transl Neurol. 2022 Nov;9(11):1715-1726. doi: 10.1002/acn3.51668. Epub 2022 Oct 10. Ann Clin Transl Neurol. 2022. PMID: 36217298 Free PMC article.
OBJECTIVE: Ornithine transcarbamylase deficiency (OTC-D) is an X-linked metabolic disease and the most common urea cycle disorder. Due to high phenotypic heterogeneity, ranging from lethal neonatal hyperammonemic events to moderate symptoms and even asymptomatic ind …
OBJECTIVE: Ornithine transcarbamylase deficiency (OTC-D) is an X-linked metabolic disease and the most common urea cycle disor …
Glycerol and testicular activity: the good, the bad and the ugly.
Crisóstomo L, Alves MG, Calamita G, Sousa M, Oliveira PF. Crisóstomo L, et al. Mol Hum Reprod. 2017 Nov 1;23(11):725-737. doi: 10.1093/molehr/gax049. Mol Hum Reprod. 2017. PMID: 28961924 Review.
Glycerol is metabolized via intermediary metabolism by a group of reactions centred at the glycerol-3-phosphate shuttle, which links the metabolic pathway of glucose, lipids and oxidative phosphorylation, illustrating its high relevance for biol …
Glycerol is metabolized via intermediary metabolism by a group of reactions centred at the glycerol-3-phosphate …
Characterization of the O-Glycoproteome of Porphyromonas gingivalis.
Veith PD, Shoji M, Scott NE, Reynolds EC. Veith PD, et al. Microbiol Spectr. 2022 Feb 23;10(1):e0150221. doi: 10.1128/spectrum.01502-21. Epub 2022 Jan 5. Microbiol Spectr. 2022. PMID: 34985300 Free PMC article.
Interestingly, a strong bias against the O-glycosylation of abundant proteins exposed to the cell surface such as abundant T9SS cargo proteins, surface lipoproteins, and outer membrane beta-barrel proteins was observed. In contrast, the great majority of proteins associate …
Interestingly, a strong bias against the O-glycosylation of abundant proteins exposed to the cell surface such as abundant T9SS cargo protei …
SGLT1 and SGLT2 inhibition, circulating metabolites, and cerebral small vessel disease: a mediation Mendelian Randomization study.
Lv Y, Cheng X, Dong Q. Lv Y, et al. Cardiovasc Diabetol. 2024 May 7;23(1):157. doi: 10.1186/s12933-024-02255-6. Cardiovasc Diabetol. 2024. PMID: 38715111 Free PMC article.
BACKGROUND: Sodium-glucose cotransporter 2 (SGLT2) and SGLT1 inhibitors may have additional beneficial metabolic effects on circulating metabolites beyond glucose regulation, which could contribute to a reduction in the burden of cerebral small vessel disease (CSVD) …
BACKGROUND: Sodium-glucose cotransporter 2 (SGLT2) and SGLT1 inhibitors may have additional beneficial metabolic effects on circulati …
448 results